Viatris Director Reports RSU Vesting and New Equity Grant
Viatris Inc
Subscribe to track VTRS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Viatris Director Reports RSU Vesting and New Equity Grant
Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low
Insider: Vivaldi Coelho Rogerio Relationship: Director
Transaction: • Type: Grant/Vesting (RSUs) • Shares Acquired: 24,835 (Vested) • Grant Awarded: 15,890 RSUs • Price: $0.00 • Owned After: 46,526
Key Insight: Routine director compensation involving the vesting of previous RSU awards and the granting of new restricted stock units. No open market activity.
Market Context: Transaction represents standard annual equity compensation for directors, representing <0.01% of shares outstanding.
Comprehensive Analysis
SEC Filing Analysis: Viatris Inc (VTRS)
Executive Summary
- Trading Significance: Low
- Key Takeaway: Routine director compensation involving RSU vesting and new annual grants; no open market buying or selling.
- Market Impact: Neutral - This is a standard compensation event with no signaling value regarding market sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Viatris Inc |
| Ticker Symbol | VTRS |
| CIK | 0001792044 |
| Industry | Pharmaceutical Preparations |
Insider Information
| Field | Value |
|---|---|
| Name | Vivaldi Coelho Rogerio |
| CIK | 0001610381 |
| Title/Position | Director |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-03-06 |
| Transaction Code | M (Exercise/Vesting) & A (Grant) |
| Security Type | Common Stock & RSUs |
| Shares Vested | 24,835 |
| Shares Granted | 15,890 |
| Price Per Share | $0.00 |
| Total Value | $0 (Compensation) |
| Shares Owned After | 46,526 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 (Non-market transaction) |
| % of Market Cap | 0.00% |
| Shares Transacted | 24,835 (Vested) |
| % of Shares Outstanding | ~0.002% |
| Post-Transaction Ownership | 46,526 shares (0.004% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: With a market cap of $17.19 billion, this compensation event is financially immaterial.
- Ownership Concentration: The insider holds a negligible percentage of the 1.15 billion shares outstanding.
- Dilution Impact: The vesting and new grants are part of the standard stock incentive plan and do not represent significant unexpected dilution.
- Transaction Significance: The transaction volume is well below the 0.1% threshold required for moderate significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: This is a scheduled vesting of restricted stock units and a new grant. It does not reflect a discretionary investment decision by the insider.
Volume & Sentiment
- Expected Volume Impact: None.
- Sentiment Indicator: Neutral.
Additional Context
Transaction Notes
- Timing: The transaction date (March 6) aligns with the company's annual vesting and grant cycle for directors.
- Details: The insider acquired 23,660 shares via RSU vesting plus 1,175 shares from Dividend Equivalent Units (DEUs). Simultaneously, they were granted 15,890 new RSUs vesting in 2027.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.